Selexis SASelexis SA
  • Services
    • Overview
    • Cell Line Development
    • Lead Identification
    • Genome Characterization
    • GENE to GMP
  • Technology
    • Overview
    • Gene Technology and Procedures – Recombinant Protein Production with CHO Cells
    • Media and Feed Strategies
    • Proprietary CHO-K1 Cell Line
    • Whole-Genome Sequencing
  • Programs
  • Applications
    • Overview
    • Bioproduction
    • Preclinical Production
    • Target Discovery
    • Cell-Based Assays
    • Diagnostics
  • About Us
    • Overview
    • Corporate Leadership
    • Scientific Leadership
    • Board of Directors
    • Company History
    • Business Development
    • Investors
    • Partners
    • JSR Life Sciences
  • Newsroom
    • Latest News
    • Archives
    • Calendar
    • Media Contact
    • Press Kit
    • Xpressions Blog
  • Careers
    • Overview
    • Open Positions
    • Great Place to Work
    • Submit Resume
  • Contact

Selexis: It’s a Great Place to Work®

Xpressions Blog: Selexis: It’s a Great Place to Work®




Selexis: It’s a Great Place to Work®

Written by Igor Fisch, PhD on May 17, 2018

The important thing is not to stop questioning. Curiosity has its own reason for existing. – Albert Einstein

As an entrepreneur, I know firsthand how thrilling it is to start a new company. We aim for success, and we determine for ourselves what that success will look like. Maybe it’s increased sales growth; maybe it’s attracting capital or top talent. Though these factors are reasonable measurements of success on the surface, Selexis believes success depends on so much more. We trust it is a direct result of creating a positive and supportive environment for our employees. We know, above all, our employees are the most valuable asset we have as a company. To that end, we wanted to know: Do our employees look forward to coming to work every day? Are we helping them achieve fulfillment? Are we providing both the challenges and the resources they need to nurture both their work and home lives? That’s why we submitted the company for evaluation in the “Best Companies to Work for in Switzerland” study carried out by Great Place to Work®. We were thrilled to be notified that we had earned a place on this year’s prestigious list of Swiss companies in the category of companies with 20-49 employees. Selexis is a Great Place to Work because our employees believe in the company and what we are doing. They believe we offer an environment in which to thrive and achieve happiness in their careers and at home. What more could an employer want?

When I look around today, I see not only our employees, but a loyal extended family who, even after years of serving the company, are still working hard to help Selexis achieve its collective mission to help our industry bring life-saving medicines to patients in need. With less than 40 employees, we have accomplished so much. In fact, we signed our 100th commercial license agreement just last month, meaning that over 100 human clinical trials are using or have used our technologies. I remain amazed at how such a small team can create so much momentum.

Achieving this recognition, according to Great Place to Work Switzerland, is a testament that our employees believe that Selexis has an “especially trustworthy, appreciative and attractive workplace culture.” The submission process involved completing both an employee survey and a comprehensive culture audit. Selexis conducted an in-depth, anonymous survey of our employees which revealed that 96% of our employees believe Selexis is a great place to work. The survey also uncovered areas where Selexis could improve, creating specific, actionable takeaways.

In addition to the survey, Selexis also drafted and designed a lengthy culture audit covering topics such as hiring and welcoming, communication, recognition and career development, among others. In this audit, we provided thoughtful, concrete examples of all of the ways Selexis supports, engages and celebrates its employees.

I knew we had something special in our people. Recognition as a Great Place to Work only solidified that belief for me. Congratulations to every employee whose hard work, talent and dedication makes Selexis a Great Place to Work. I am grateful. This is success.

We are always looking for ‘great’ talent. If you are interested in a career at Selexis, please submit your resume.

  • Latest News
  • Archives
  • Calendar
  • Media Contact
  • Press Kit
  • Xpressions Blog
  • Keywords:


    Great Place to WorkSwitzerlandentrepreneurcareeremployees

    Sitemap

    • Home
    • Services
    • Overview
    • Cell Line Development
    • Lead Identification
    • Genome Characterization
    • GENE to GMP
    • Technology
    • Overview
    • Gene Technology and Procedures
    • Media and Feed Strategies
    • Proprietary CHO-K1 Cell Line
    • Genome and Transcriptome
    • Selexis Online Library
    • Overview
    • Technology Sheets
    • Scientific Publications
    • Scientific Posters
    • White Papers and Articles
    • Videos
    • Fact Sheets
    • Presentations
    • Applications
    • Overview
    • Bioproduction
    • Preclinical Production
    • Target Discovery
    • Cell-Based Assays
    • Diagnostics
    • Programs
    • Licensing
    • Publications
    • Innovation Timeline
    • Technology FAQs
    • About Us
    • Overview
    • Corporate Leadership
    • Scientific Leadership
    • Board of Directors

    • Company History
    • Business Development
    • Investors
    • Partners
    • JSR Life Sciences
    • Newsroom
    • Latest News
    • Archives
    • Calendar
    • Media Contact
    • Press Kit
    • Xpressions Blog
    • Contact Us
    • General Inquiries
    • Corporate Headquarters
    • Careers
    • Overview
    • Open Positions
    • Great Place to Work
    • Submit Resume
    • Legal
    • Privacy
    • Cookies
    • Social Media

    Great Place to Work 2020

    About Selexis

    Selexis SA, a JSR Life Sciences Company, is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover, develop and commercialize innovative medicines and vaccines. Our global partners are utilizing Selexis cell line development technologies to advance more than 115 drug products in clinical development and the manufacture of five commercial products. As part of a comprehensive drug development process, the Company’s technologies shorten development timelines and reduce manufacturing risks.

    JSR Logo

    • Terms of Use
    • Privacy
    • Cookies
    • Social Media
    • LinkedIn
    • Twitter
    • Facebook
    Selexis SA Copyright © . All Rights Reserved.

     

      • Services
        • Overview
        • Cell Line Development
        • Lead Identification
        • Genome Characterization
        • GENE to GMP
      • Technology
        • Overview
        • Gene Technology and Procedures – Recombinant Protein Production with CHO Cells
        • Media and Feed Strategies
        • Proprietary CHO-K1 Cell Line
        • Whole-Genome Sequencing
      • Programs
      • Applications
        • Overview
        • Bioproduction
        • Preclinical Production
        • Target Discovery
        • Cell-Based Assays
        • Diagnostics
      • About Us
        • Overview
        • Corporate Leadership
        • Scientific Leadership
        • Board of Directors
        • Company History
        • Business Development
        • Investors
        • Partners
        • JSR Life Sciences
      • Newsroom
        • Latest News
        • Archives
        • Calendar
        • Media Contact
        • Press Kit
        • Xpressions Blog
      • Careers
        • Overview
        • Open Positions
        • Great Place to Work
        • Submit Resume
      • Contact
      The new European data protection law requires us to inform you of the following before you use our website:

      We use cookies to customize your experience, perform analytics and deliver personalized advertising on our site. By clicking “I agree” below, you consent to the use by us and our third-party partners of cookies and data gathered from your use of our website. See our Privacy Policy to learn more about the use of data and your rights. You also agree to our Terms of Service.


      I AgreeContinue to site
      Privacy & Cookies Policy

      Privacy Overview

      This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
      Necessary
      Always Enabled

      Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

      Non-necessary

      Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

      SAVE & ACCEPT